Pharma Watch

Leading Pharma Leading Pharma

Challenged Pharma Challenged Pharma

FDA Places Clinical Hold on LogicBio’s Gene Therapy Treatment

FDA Places Clinical Hold on LogicBio’s Gene Therapy Treatment

LogicBio Therapeutics  announced that the U.S. FDA has placed a clinical hold on the Investigational New Drug (IND) submission for LB-001 for the treatment of methylmalonic acidemia (MMA) pending the resolution of certain clinical and nonclinical questions. LogicBio...

subscribe

University at Buffalo
subscribe

Pin It on Pinterest